A multinational pharma trained 700+ investigators and site staff for a Phase 3 breast cancer trial on Within3's learning hub.
The sponsor needed to train 700+ principal investigators and staff quickly for a Phase 3 triple-negative breast cancer trial while cutting travel and admin. It used Within3's Group Engagement Application with a Clinical Virtual Learning Hub, completion certificates and progress tracking. The page reports 700+ participants completed training at their own pace, with audit documentation for EMA inspection preparation.
Within3 is a medical affairs insights platform, used by pharma for virtual advisory boards and AI-supported insights reporting from field, trial and social data
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Within3 on its own site — read the original case study on within3.com ↗
Related use cases
- 01A top-5 pharma used Within3's AI-powered Launch Intelligence to find mental health professionals as an unplanned prescriber segment.
- 02A top pharma used Within3's Launch Intelligence to address diagnostic delays for a chronic gastrointestinal condition.
- 03A midsize pharma's medical affairs team replaced manual insight reporting with Within3's AI-supported Insights Reporting.
- 04A global pharma unified fragmented medical and commercial intelligence on Within3 for a launch in an unfamiliar therapeutic area.
- 05A medical affairs team ran two asynchronous virtual advisory boards across four European countries on Within3.
- 06A medical affairs team used a 17-day Within3 virtual advisory board to gather internal feedback on training.